In Vitro Fertilization: Clinical Trials

17 trials for In Vitro Fertilization, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 7 terminated, 3 unknown. 17 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 417Completed 7, Terminated 7, Unknown 3

Follow In Vitro Fertilization: new trials by email Literature Review of In Vitro Fertilization trials Research Report on In Vitro Fertilization

Trials (filtered) newest first · largest first

All 17 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
hCG Priming in Women With Low Ovarian Reserve
Ovitrelle - Infertility, Female, Ovarian Reserve
Phase 4CompletedCopenhagen University Hospital, Rigshospitalet202020-12-272022-08-25
Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSI
Triptorelin acetate, Cetrorelix, recombinant-FSH or recombinant-FSH + human Menopausal Gonadotropin - In Vitro Fertilization, Intracytoplasmic Sperm Injection
Phase 4CompletedDamascus University502020-08-222023-10-24
Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI
Triptorelin acetate, Cetrorelix, recombinant-FSH or recombinant-FSH + human Menopausal Gonadotropin - In Vitro Fertilization, Infertility
Phase 4CompletedDamascus University502020-08-222023-10-24
Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes.
Triptorelin acetate, Cetrorelix, recombinant-FSH or recombinant-FSH + human Menopausal Gonadotropin - In Vitro Fertilization, Intracytoplasmic Sperm Injection
Phase 4CompletedDamascus University502019-12-222023-10-24
Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.
Triptorelin acetate, Cetrorelix, recombinant-FSH or recombinant-FSH + human Menopausal Gonadotropin - In Vitro Fertilization, Intracytoplasmic Sperm Injection
Phase 4CompletedDamascus University502019-12-222023-10-24
Patients' Preference for Subcutaneous or Vaginal Progesterone as Luteal Support in IVF/ICSI Cycles
Progesterone 25 MG subcutaneous, Micronized progesterone 200 MG, recombinant FSH - Infertility, In Vitro Fertilization
Phase 4TerminatedAndros Day Surgery Clinic602016-12-202020-01-10
Corifollitropin Alfa Application in PCOS Patients
Corifollitropin alfa - In Vitro Fertilization
Phase 4UnknownShin Kong Wu Ho-Su Memorial Hospital302014-01-012014-08-13
Age Versus Ovarian Reserve Markers Based Therapy in IVF (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycles
rFSH, buserelin - In Vitro Fertilization, Ovarian Stimulation
Phase 4TerminatedAndros Day Surgery Clinic1942013-03-012016-12-23
Delayed Start to Ovarian Stimulation
Ganirelix acetate - Diminished Ovarian Reserve, Infertility
Phase 4TerminatedUniversity of California, San Francisco302012-05-012021-06-15
Comparing Coasting by Withholding GnRH Agonist With GnRH Antagonist
GnRH antagonist, withdrawing GnRH agonists - In Vitro Fertilization
Phase 4UnknownShin Kong Wu Ho-Su Memorial Hospital1202011-01-012011-05-04
The Influence of Dopamine Agonist Cabergoline on Oocyte Maturation
the timing cabergoline administration - In Vitro Fertilization
Phase 4CompletedShin Kong Wu Ho-Su Memorial Hospital1202010-01-012011-07-21
Cetrotide Treatment Optimization
Cetrotide (Ovarian stimulation) - In Vitro Fertilization, Intracytoplasmic Sperm Injection
Phase 4TerminatedBart CJM Fauser6172009-02-012014-03-19
Trial Comparing Start Stimulation of Recombinant Follicle Stimulating Hormone (rFSH) on Cycle Day 2 Versus Cycle Day 5 in In Vitro Fertilization (IVF)
Mild stimulation - in Vitro Fertilization, Ovulation Induction
Phase 4TerminatedUMC Utrecht1472009-01-012019-01-29
Methylprednisolone Addition in IVF Treatment of Infertile Couples
In vitro fertilization treatment for infertility - In Vitro Fertilization
Phase 4UnknownUniversitair Ziekenhuis Brussel1302009-01-012010-10-14
A Study of the Effects of a Novel Ovarian Stimulation Regimen on Embryo Aneuploidy Rates in In Vitro Fertilization (IVF)
Ovarian stimulation - In Vitro Fertilization
Phase 4TerminatedBart CJM Fauser342008-10-012013-07-22
EXpression PRofile Endometrium Samples Study
Gonal -f® [r-hFSH], Ovitrelle® [r-hCG alfa], Gonadotropin-releasing hormone (GnRH) Agonist - In Vitro Fertilization
Phase 4TerminatedMerck KGaA, Darmstadt, Germany272008-08-012013-12-27
Nordic Luveris Study
recombinant luteinizing hormone (Luveris), recombinant follicle stimulating hormone (Gonal-f) - Infertility, In Vitro Fertilization
Phase 4CompletedCopenhagen University Hospital, Rigshospitalet5262003-08-012007-11-05

Narrower conditions

Infertility (8)  ·  Polycystic Ovary Syndrome (3)  ·  Aneuploidy (1)  ·  Infertility, Female (1)  ·  Ovarian Hyperstimulation Syndrome (1)

Broader conditions

Genital Diseases (10)  ·  Urogenital Diseases (10)  ·  Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Genital Diseases, Female (4)  ·  Adnexal Diseases (3)  ·  Cysts (3)  ·  Endocrine System Diseases (3)  ·  Gonadal Disorders (3)  ·  Neoplasms (3)  ·  Ovarian Cysts (3)  ·  Ovarian Diseases (3)  ·  Chromosome Aberrations (1)  ·  Infertility (1)  ·  Pathologic Processes (1)

Interventions

Chorionic Gonadotropin (6)  ·  cetrorelix (6)  ·  Triptorelin Pamoate (5)  ·  Menotropins (4)  ·  follitropin alfa (4)  ·  ganirelix (3)  ·  Glycoprotein Hormones, alpha Subunit (2)  ·  Ovulation Induction (2)  ·  Progesterone (2)  ·  follitropin beta (2)  ·  Buserelin (1)  ·  Gonadotropin-Releasing Hormone (1)  ·  Injections, Subcutaneous (1)  ·  LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- (1)  ·  Luteinizing Hormone (1)

Sponsors

Damascus University (4)  ·  Shin Kong Wu Ho-Su Memorial Hospital (3)  ·  Andros Day Surgery Clinic (2)  ·  Bart CJM Fauser (2)  ·  Copenhagen University Hospital, Rigshospitalet (2)  ·  Merck KGaA, Darmstadt, Germany (1)  ·  UMC Utrecht (1)  ·  Universitair Ziekenhuis Brussel (1)  ·  University of California, San Francisco (1)

Countries

Syria (4)  ·  Netherlands (3)  ·  Taiwan (3)  ·  Denmark (2)  ·  Italy (2)  ·  Belgium (1)  ·  France (1)  ·  Greece (1)  ·  United States (1)

Top investigators

Abdul Hakim Nattouf, MD, PhD (4)  ·  Marwan Alhalabi, MD, PhD (4)  ·  Sally Kadoura, B Pharm, MD (4)  ·  Jiann-Loung Hwang, MD (3)  ·  Nick S Macklon, Prof, PhD (2)  ·  Adolfo Allegra, MD (1)  ·  Anders N Andersen, professor (1)  ·  Anja B Pinborg, MD (1)  ·  Bart C Fauser, Prof, PhD (1)  ·  Basil Tarlatzis, Professor (1)  ·  Mitchell Rosen, MD (1)

Results publications

PMID 18024487, PMID 23809501, PMID 24129613, PMID 24929258, PMID 36721920, PMID 37354554